Repository details

Liverpool COVID-19 Drug Interactions

Name of repository
Liverpool COVID-19 Drug Interactions
Repository URL
https://www.covid19-druginteractions.org/
Subject(s)
Description
The COVID-19 pandemic has affected every country in the world. It is well documented that those most susceptible to the worst outcomes of COVID-19 are the immunocompromised and those with underlying comorbidities. Therefore, patients requiring treatment for COVID-19 will also be on additional medication, posing a risk for drug-drug interactions (DDIs). In order to address this, the Liverpool Drug Interactions website team developed this freely available drug interactions resource to provide information on the likelihood of interactions between the experimental agents used for the treatment of COVID-19 and commonly prescribed co-medications.
Contact(s)
Keyword(s)
Persistent identifier(s) of the repository
Repository type(s)
  • disciplinary
Mission statement for designated community
https://www.covid19-druginteractions.org/about
Research data repository language(s)
  • English
Data and/or service provider
  • dataProvider

Institutions (9)

Institution
British HIV Association
Additional name(s)
  • BHIVA
Institution
Country
United Kingdom
Type(s) of responsibility
  • funding
Type of institution
non-profit
Institution
European AIDS Clinical Society
Additional name(s)
  • EACSociety
  • EACS
Institution
Country
European Union
Type(s) of responsibility
  • funding
Type of institution
non-profit
Institution
More partners
Country
International
Type(s) of responsibility
  • sponsoring
Type of institution
commercial
Institution
National Institute for Health Research
Additional name(s)
  • NIHR
Institution
Country
United Kingdom
Type(s) of responsibility
  • funding
Type of institution
non-profit
Institution
Radboud University Nijmegen Medical Centre
Additional name(s)
  • RUNMC
  • Radboudumc
Institution
Country
Netherlands
Type(s) of responsibility
  • general
Type of institution
non-profit
Institution
UK Research and Innovation
Additional name(s)
  • United Kingdom Resarch and Innovation
  • UKRI
Institution
Country
United Kingdom
Type(s) of responsibility
  • funding
Type of institution
non-profit
Institution
University of Basel
Institution
Country
Switzerland
Type(s) of responsibility
  • general
Type of institution
non-profit
Institution
University of Liverpool, Centre of Excellence in Infectious Diseases Research
Additional name(s)
  • CEIDR
Country
United Kingdom
Type(s) of responsibility
  • general
Type of institution
non-profit
End date of responsibility
2022
Institution
University of Liverpool, Pharmacology Research Labs, Liverpool Drug Interactions Group
Country
United Kingdom
Type(s) of responsibility
  • general
Type of institution
non-profit

Policies (1)

Policy Name
Terms & Conditions

Database access

Type of access to research data repository
open

Data access (1)

Type of access to data
open

Data licenses (1)

DataLicense
Copyrights

Data upload (1)

Type of data upload
closed
Data citation guideline
https://www.covid19-druginteractions.org/prescribing_resources
Enhanced Publication
unknown
Quality management
unknown

Remarks

Entry date
2020-04-24
Last update
2024-05-22
Back to search
Submit a change request
Get a badge
The DataCite logo

Cite this re3data.org record:

re3data.org: Liverpool COVID-19 Drug Interactions; editing status 2024-05-22; re3data.org - Registry of Research Data Repositories. http://doi.org/10.17616/R31NJMR7 last accessed: 2025-04-27